HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 47 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,045,285 | +1.9% | 9,500,000 | 0.0% | 0.09% | -4.3% |
| Q2 2023 | $7,896,189 | -2.1% | 9,500,000 | 0.0% | 0.09% | -1.1% |
| Q1 2023 | $8,069,315 | -52.8% | 9,500,000 | -50.8% | 0.10% | -44.4% |
| Q2 2022 | $17,114,000 | -15.5% | 19,296,000 | -16.5% | 0.17% | -13.6% |
| Q1 2022 | $20,264,000 | – | 23,096,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,432 | $63,617,000 | 4.32% |
| Western Asset Management Company, LLC | 15,600,000 | $13,690,000 | 4.04% |
| CAMDEN ASSET MANAGEMENT L P /CA | 70,849,000 | $61,727,000 | 1.84% |
| ZAZOVE ASSOCIATES LLC | 16,992,000 | $14,985,000 | 1.32% |
| Penn Mutual Asset Management, LLC | 1,305,000 | $1,137,000 | 1.32% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 64,750,000 | $56,413,000 | 0.72% |
| CQS (US), LLC | 10,000,000 | $8,777,000 | 0.61% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,859,000 | $25,319,000 | 0.40% |
| Context Capital Management, LLC | 4,122 | $3,632,000 | 0.24% |
| Hudson Bay Capital Management LP | 19,500,000 | $17,152,000 | 0.23% |